Cargando…
Regulation of Mucin 1 and multidrug resistance protein 1 by honokiol enhances the efficacy of doxorubicin-mediated growth suppression in mammary carcinoma cells
Understanding the link between chemoresistance and cancer progression may identify future targeted therapy for breast cancer. One of the mechanisms by which chemoresistance is attained in cancer cells is mediated through the expression of multidrug resistance proteins (MRPs). Acquiring drug resistan...
Autores principales: | Thulasiraman, Padmamalini, Johnson, Andrea Butts |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922838/ https://www.ncbi.nlm.nih.gov/pubmed/27221150 http://dx.doi.org/10.3892/ijo.2016.3534 |
Ejemplares similares
-
Overexpression of Mucin 1 Suppresses the Therapeutical Efficacy of Disulfiram against Canine Mammary Tumor
por: Zhao, Ying, et al.
Publicado: (2020) -
Involvement of Fatty Acid Binding Protein 5 and PPARβ/δ in Prostate Cancer Cell Growth
por: Morgan, Elwin, et al.
Publicado: (2010) -
Enhancing the anti-glioma therapy of doxorubicin by honokiol with biodegradable self-assembling micelles through multiple evaluations
por: Gao, Xiang, et al.
Publicado: (2017) -
Honokiol is a FOXM1 antagonist
por: Halasi, Marianna, et al.
Publicado: (2018) -
Honokiol Inhibits HIF-1α-Mediated Glycolysis to Halt Breast Cancer Growth
por: Yi, Xianglan, et al.
Publicado: (2022)